Research classification: Experimental neurobiology literature
Compound overview
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH).
Published research
Experimental studies have explored Semax in animal models of cerebral ischemia and related behavioral or neurological endpoints. A published study evaluated ischemic cortical injury in an experimental model.
Evidence limitations
Animal ischemia experiments do not provide reliable conclusions about the clinical safety, efficacy, or recommended use of a commercial research product.
Primary publications and technical references
- Experimental cerebral ischemia study (2007) — view source
- Semax and Selank in a rat neurological model (2017) — view source
Literature summaries are educational and refer only to the specific preparations and methods studied by the cited authors. These publications do not demonstrate that any APEP Biolabs material is suitable for human or veterinary use. Not medical advice. Laboratory research only. Do not administer or consume research materials.